Helpdesk

Sales contact

Home > Resources > Working with patient associations: What is the key to a positive interaction?

Working with patient associations: What is the key to a positive interaction?

Last updated: June 24, 2024

What rare disease patients and families want is a simpler life.
Discover here what makes the relationship between the members of the patients’ association and a company work so well.

Subscribe to our newsletter

ePRO in early phase oncology trials: A revolution on the...

Patient-Reported Outcomes in early-phase oncology clinical trialsA Stepping Stone to...

Answering the Sustainability Call: Digital Health Technologies and eCOA

Kayentis secures Silver Medal in EcoVadis sustainability evaluation with significant...

Engage patients throughout the clinical trial journey

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

Navigating BYOD in Clinical Research: Insights for Clinical Trial Success

December 4 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET

BYOD

As the Bring Your Own Device (BYOD) model gains momentum in clinical research, understanding what to consider and how to...